Myriam L. Taibi

Myriam Taibi practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Myriam Taibi's NPI, 1255969820, was assigned on March 30, 2020. Myriam Taibi graduated from Geisel School of Medicine at Dartmouth in 2020. Myriam Taibi holds Massachusetts license 1013845.

Myriam Taibi's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Myriam Taibi's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Myriam Taibi is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Myriam Taibi to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Myriam Taibi practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Myriam Taibi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Myriam Taibi is licensed in Massachusetts.

CMS data shows 573 Medicare services from Myriam Taibi across 4 procedure codes in 2024, for 248 Medicare patients. Medicare paid $57,341 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Myriam Taibi in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Myriam Taibi's median patient age at 74, with 56% women.

In 2024, Myriam Taibi wrote 99 Medicare Part D claims for 46 patients. 86% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $797 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Myriam Taibi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Myriam Taibi in 2016. 2016 was the busiest year, with 3. The most frequent topics are Lung Neoplasms. Myriam Taibi has published most often in Clin Cancer Res. Myriam Taibi's most frequent co-authors are Daniel Botelho Costa, MD, David M. Jackman, MD and Bruce Evan Johnson, MD.

Myriam Taibi graduated from Geisel School of Medicine at Dartmouth in 2020.